Delivery Order N6817122D2007-N6817126FS002
- Not listed
- The Defense Health Agency awarded a delivery order to Bio-Rad Laboratories S.R.L. for laboratory supplies with a ceiling value of $14.7K and an ultimate completion date of January 2, 2025. This firm fixed-price delivery order, issued on December 19, 2024, will be performed in Italy and represents one of multiple task orders under Bio-Rad Laboratories S.R.L.'s single-award Indefinite Delivery Contract (IDC N6817122D2007) with the Defense Health Agency. The underlying IDC, valued at...
- Bio-Rad Laboratories S.R.L. was awarded a delivery order against an indefinite-delivery contract with the Defense Health Agency for laboratory supplies. The $9,356.20 firm fixed price order is to provide materials to the U.S. Naval Hospital Sigonella in Italy through July 1, 2021. This delivery order was issued on June 21, 2021 under the prime contractor's single award, indefinite-delivery contract vehicle with the Defense Health Agency valued at up to $236,240 through September 2027. No...
- The U.S. Defense Health Agency (DHA) awarded a Delivery Order contract to Bio-Rad Laboratories S.R.L., an Italian subsidiary of the global laboratory equipment manufacturer Bio-Rad Laboratories, Inc. The contract, valued at $6,734.21, is for the provision of various laboratory supplies to support U.S. military medical facilities in Italy. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) with a $236,240.38 ceiling value, which was awarded to Bio-Rad Laboratories S.R.L....
- The Defense Health Agency (DOD) awarded a $10,313 delivery order to Bio-Rad Laboratories S.R.L. for laboratory supplies. Bio-Rad Laboratories S.R.L. is a subsidiary of Bio-Rad Laboratories, Inc. and will provide the supplies on a firm fixed price basis, with performance taking place in Italy between September 21, 2023 and October 15, 2023. The Defense Health Agency supports the medical readiness of military forces and provides health care to beneficiaries worldwide under the Department of...
- The Defense Health Agency (DOD) awarded a $2,318.52 firm fixed price delivery order contract to Bio-Rad Laboratories S.R.L. for laboratory supplies. The prime contractor, Bio-Rad Laboratories S.R.L., is a subsidiary of Bio-Rad Laboratories, Inc. The place of performance will be Italy, and the period of performance is July 19, 2023 through August 2, 2023. No major subcontractors or set aside designations were identified. The Defense Health Agency supports the military health system and ensures...
- The Defense Health Agency awarded a $5,170.63 firm fixed price delivery order to Bio-Rad Laboratories S.R.L. for laboratory supplies. The order is under an indefinite-delivery/indefinite-quantity contract vehicle and has a period of performance through September 15, 2022. Bio-Rad Laboratories S.R.L. is a subsidiary of Bio-Rad Laboratories, Inc., which will serve as the prime contractor. No set-aside designation was used for this award to support the Defense Health Agency's mission activities...
- This federal contract award was made by the Defense Health Agency (DHA) to Bio-Rad Laboratories S.R.L., an Italian subsidiary of the global laboratory equipment manufacturer Bio-Rad Laboratories, Inc. The $5,757.38 firm fixed-price delivery order is for laboratory supplies, including hematology controls, immunoassay controls, drugs of abuse kits, and various consumable laboratory materials. The contract is part of a larger $236,240.38 Indefinite Delivery Contract (IDC) vehicle, N6817122D2007,...
- This federal contract award was made by the Defense Health Agency (DHA) to Bio-Rad Laboratories S.R.L., an Italian subsidiary of the global laboratory equipment manufacturer Bio-Rad Laboratories, Inc. The $11,866.15 firm fixed-price delivery order is for the provision of laboratory supplies, including hematology controls, immunoassay controls, drugs of abuse kits, and various consumable laboratory materials. The award is part of a larger $236,240.38 Indefinite Delivery Contract (IDC) vehicle,...
- This is a federal contract award valued at $1,250.26 issued by the Defense Health Agency (DHA) to Bio-Rad Laboratories S.R.L., an Italian subsidiary of the global manufacturer Bio-Rad Laboratories, Inc. The contract is for the delivery of laboratory supplies, including hematology controls, immunoassay controls, drugs of abuse kits, and various consumable laboratory materials. This award is not associated with a small business set-aside. Bio-Rad Laboratories S.R.L. holds a larger $236,240.38...
- Bio-Rad Laboratories Inc. was awarded a $244,260 firm fixed-price delivery order by the Defense Health Agency on June 2, 2025, for consumables and reagent products supporting serological automated analyzer systems. The work will be performed in Silver Spring, Maryland, with an ultimate completion date of June 5, 2025. This delivery order is issued under Bio-Rad's larger $13.77 million single-award Indefinite Delivery Contract with the Defense Health Agency for serological automated analyzers,...
- N6817122D2007Indefinite Delivery Contract
- N6817122D2007-N6817126FS002Delivery Order
The Defense Health Agency awarded a $2,477.70 firm fixed-price delivery order to Bio-Rad Laboratories S.R.L., an Italian subsidiary of Bio-Rad Laboratories, Inc., on November 4, 2025, with an ultimate completion date of November 19, 2025. This delivery order procures laboratory supplies for immunochemistry Vitros 5600 and chemistry Vitros 350 analyzers located in the laboratory department of U.S. Naval Hospital Sigonella in Italy. The award was made on a full and open competitive basis without small business set-aside designation and is issued under an Indefinite Delivery Contract with a ceiling value of $236,240.38 that extends through September 6, 2027. Bio-Rad Laboratories S.R.L. serves as the prime contractor with no identified subcontractors. Bio-Rad Laboratories S.R.L. has maintained a consistent track record of supplying critical laboratory diagnostics and consumables to support U.S. military medical operations at overseas facilities since 2013. The company's previous deliveries to the Defense Health Agency have included hematology controls, immunoassay controls, drugs of abuse testing kits, and various analyzer consumables essential to medical readiness. This delivery order represents the continuation of the company's specialized role in maintaining diagnostic testing capabilities for military healthcare beneficiaries stationed in the European theater, supporting the broader Defense Health Agency mission to ensure medical readiness across the defense health system.